MedPath

NATIONAL INSTITUTES OF HEALTH

NATIONAL INSTITUTES OF HEALTH logo
🇺🇸United States
Ownership
Subsidiary, Private
Established
1948-01-01
Employees
1K
Market Cap
-
Website
http://www.nidcr.nih.gov

Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

Completed
Conditions
Genodermatosis
Xeroderma Pigmentosum
Trichothiodystrophy Syndromes
Skin Neoplasms
Cockayne Syndrome
First Posted Date
1999-11-04
Last Posted Date
2025-05-20
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
709
Registration Number
NCT00001813
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Women's Health Trial: Feasibility Study in Minority Populations

Phase 3
Completed
Conditions
Heart Diseases
Myocardial Ischemia
Postmenopause
Cardiovascular Diseases
Coronary Disease
First Posted Date
1999-10-28
Last Posted Date
2017-02-14
Lead Sponsor
National Cancer Institute (NCI)
Registration Number
NCT00000481

Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes

Phase 3
Completed
Conditions
Diabetic Nephropathy
Interventions
First Posted Date
1999-10-19
Last Posted Date
2018-03-07
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
160
Registration Number
NCT00004266
Locations
🇺🇸

Hennepin County Medical Center, Minneapolis, Minnesota, United States

Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis

Not Applicable
Withdrawn
Conditions
Psoriasis
First Posted Date
1999-10-19
Last Posted Date
2018-03-02
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Registration Number
NCT00004468

Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome

Phase 3
Terminated
Conditions
Hemolytic Uremic Syndrome
Interventions
Drug: Placebo
First Posted Date
1999-10-19
Last Posted Date
2017-06-01
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
145
Registration Number
NCT00004465
Locations
🇺🇸

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

🇺🇸

Ohio State University Children's Hospital, Columbus, Ohio, United States

🇺🇸

Indiana University Cancer Center, Indianapolis, Indiana, United States

and more 24 locations

Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen

Phase 3
Completed
Conditions
Acute Liver Failure
Interventions
First Posted Date
1999-10-19
Last Posted Date
2017-10-13
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
173
Registration Number
NCT00004467
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

University of Washington Medical Center, Seattle, Washington, United States

🇺🇸

University of California Los Angeles, Los Angeles, California, United States

and more 20 locations

Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome

Phase 2
Terminated
Conditions
Nephrotic Syndrome
Hyperlipidemia
Interventions
Drug: Placebo
First Posted Date
1999-10-19
Last Posted Date
2017-09-15
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
5
Registration Number
NCT00004466
Locations
🇺🇸

Medical City Dallas Hospital, Dallas, Texas, United States

Study of Protein Translocation in Patients With Beta-Oxidation Disorders

Completed
Conditions
Beta-Oxidation Disorder
Peroxisomal Disorders
First Posted Date
1999-10-19
Last Posted Date
2021-09-27
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
20
Registration Number
NCT00004348

Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy

Phase 2
Completed
Conditions
IgA Glomerulonephritis
Interventions
First Posted Date
1999-10-19
Last Posted Date
2025-05-04
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
96
Registration Number
NCT00004448
Locations
🇺🇸

Medical City Dallas Hospital, Dallas, Texas, United States

Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis

Phase 1
Completed
Conditions
Interstitial Cystitis
Vulvar Diseases
Interventions
Drug: Placebo
First Posted Date
1999-10-19
Last Posted Date
2025-05-04
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
139
Registration Number
NCT00004316
Locations
🇺🇸

University of Pittspurgh, Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath